By binding to the promoter of GDF1, Nkx2.5 transactivated the expression of GDF1, which may confer genetic susceptibility to CHD potentially by altering its expression, according to the results of the luciferase assay, chromatin immunoprecipitation, and DNA pulldown assay (75). This evidence concerns the gene NKX2-5 and coronary artery disorder.